SUPREMO trial findings signal change in breast cancer treatment

by Biotech Newsroom


LATEST NEWS: 6 November 2025

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, according to 10-year follow-up from an international trial on which TROG collaborated

Findings from the BIG 2-04/MRC/TROG 11.01 SUPREMO trial were published in the prestigious New England Journal of Medicine this week, providing evidence for a change in practice in treatment of some breast cancers.

The trial found that patients with early-stage breast cancer who…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC